Identification of agonistic autoantibodies

Details Identification of agonistic autoantibodies Identification of agonistic autoantibodies

2003-11-28

2010-06-22

Saunders, David A (Department: 1644)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C435S007920, C435S007950, C435S971000, C436S506000, C436S538000, C436S541000

Reexamination Certificate

active

07741050

ABSTRACT:
The invention relates to a method for detecting disease-associated autoantibodies, which recognize extracellular structures of G protein-coupled receptors, and to the use of peptides, which comprise these loops or fragments thereof, for treating autoimmune diseases.

REFERENCES:
patent: 4468470 (1984-08-01), Aalberse
patent: 6994970 (2006-02-01), Ronspeck et al.
patent: 7309488 (2007-12-01), Ogino et al.
patent: 101 23 929 (2002-11-01), None
patent: 00/39154 (2000-07-01), None
patent: WO 01/21660 (2001-03-01), None
patent: 02/16431 (2002-02-01), None
patent: 2004/067549 (2004-08-01), None
Lederman et al, Molec. Immunol., 28, 1171-1181, 1991.
Staudt Alexander et al: “Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy.” Circulation, vol. 106, No. 19, 2002, pp. 2448-2453.
Wallukat G et al: “Anti-Betai-Adrenoceptor Autoantibodies With Chronotropic Activity From the Serum of Patients With Dilated Cardiohyopathy: Mapping of Epitopes in the First and Second Extracellular Loops.” Journal of Molecular and Cellular Cardiology, vol. 27, 1995, pp. 397-406.
Harlow et al, Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory, 1988, pp. 298-299.
* Wallukat Gerd et al: “Spontaneously beating neonatal rat heart myocyte culture: A model to characterize angiotensin II AT1 receptor autoantibodies in patients with preeclampsia.” in: In Vitro Cellular and Developmental Biology Animal, vol. 38, No. 7, 2002, pp. 376-377.
* Wallukat Gerd et al: “Specific removal of beta1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy.” in: New England Journal of Medicine, vol. 347, No. 22, Nov. 28, 2002, p. 1806.
* Wallukat Gerd et al: “Autoantibodies against the beta- and muscarinic receptors in cardiomyopathy”in: HERZ, vol. 25, No. 3, 2000, pp. 261-266.
* Fu Michael L X et al: “A synthetic Peptide corresponding to the second extracellular loop of the human M2 acetylcholine receptor induces pharmacological and morphological changes in cardiomyocytes by active immunization after 6 months in rabbits” Clinical Immunology and Immunopathology, vol. 78, No. 2, 1996, pp. 203-207.
* Marino Maria et al: “Prevention of systemic lupus erythematosus in MRL/Ipr mice by administration of an immunoglobulin-binding peptide” . Nature Biotechnology, vol. 18, No. 7, Jul. 2000, pp. 735-739.
* Boros Peter et al: “Specificity and class distribution of Fc-gamma-R-specific autoantibodies in patients with autoimmune disease” in: Journal of Immunology, The Williams and Wilkins Co. Baltimore, US, vol. 152, 1994, pp. 302-306.
* MacFarlane S R et al: “Proteinase-activated receptors” in: Pharmacological Reviews, Williams and Wilkins Inc., Baltimore, MD,, US, vol. 53, No. 2, Jun. 2001, pp. 245-282.
* Belch J J F: “Raynaud's phenomenon” in: Current Opinion in Rheumatology, vol. 3, No. 6, 1991, pp. 960-966.
Dragun D et al: “Patients With Steroid Refractory Acute Vascular Rejection Develop Agonistic Antibodies Targeting Angiotensin II Type 1 Receptor” in: Transplantation Proceedings, vol. 35, No. 6, Sep. 6, 2003, pp. 2104-2105.
Dragun D et al: “Steroid-Resistant Vascular Rejection Due to Agonistic ATI-Receptor Antibodies Causing Expression of TF, MCP-1, and RANTES” in: Journal of the American Society of Nephrology, vol. 12, Sep. 2001, p. 930A.
Luther et al: “Alpha1-adrenergic receptor antibodies in patients with primary hypertension” in: Hypertension, vol. 29, No. 2, 1997, pp. 678-682.
Liao et al: “Autoantibodies against AT1-receptor and alpha1-adrenergic receptor in patients with hypertension” in: Official Journal of the Japanese Society of Hypertension, vol. 25, No. 4, Jul. 2002, pp. 641-646.
Fu et al: “Functional autoimmune epitope on alpha 1-adrenergic receptors in patients with malignant hypertension” in: Lancet, vol. 344, No. 8938, 1994, p. 1660.

Affiliated with

Also associated with

Rating

Identification of agonistic autoantibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Identification of agonistic autoantibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Identification of agonistic autoantibodies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4243682